Melanoma News and Research

Latest Melanoma News and Research

Biologists show bioelectrical signals control tumors arising from cancer-causing genes, fatty acid

Developmental biologists at Tufts University, using a tadpole model, have shown that bioelectrical signals from distant cells control the incidence of tumors arising from cancer-causing genes and that this process is impacted by levels of a common fatty acid produced by bacteria found in the tadpole and also in humans.

28 May 2014

New analysis finds that certain cancers are more concentrated in areas with high poverty

A new analysis has found that certain cancers are more concentrated in areas with high poverty, while other cancers arise more often in wealthy regions. Also, areas with higher poverty had lower cancer incidence and higher mortality than areas with lower poverty.

28 May 2014

International study provides hope to patients with advanced prostate cancer

An international study carried out with involvement of the MedUni Vienna is giving hope to patients with advanced prostate cancer. In just a few years' time, Ipilumumab could be approved as a treatment for the world's third-most common type of cancer.

26 May 2014

Peptide antibodies hit immune-response-stifling MDSCs without harming other vital cells

Scientists have found a way to target elusive cells that suppress immune response, depleting them with peptides that spare other important cells and shrink tumors in preclinical experiments, according to a paper published online by Nature Medicine.

26 May 2014

Research validates family history screening questionnaire as tool to cover multiple conditions

The family history screening questionnaire can be used to provide insight into people's susceptibility to breast, ovarian, bowel and prostate cancer, melanoma, ischaemic heart disease and type 2 diabetes.

22 May 2014

Loyola's pediatric dermatologists highlight risks related to indoor tanning

Prom season is right around the corner and with that comes dress shopping and trips to the local tanning salons for many girls.

21 May 2014

Mayo Clinic study provides key insights into aggressive form of pancreatic cancer

Mayo Clinic researchers have discovered an enzyme they say is tightly linked to how aggressive pancreatic cancer will be in a patient.

21 May 2014

Research provides key insights into most aggressive form of pancreatic cancer

Mayo Clinic researchers have discovered an enzyme they say is tightly linked to how aggressive pancreatic cancer will be in a patient.

21 May 2014

Substance from pine bark is a potential source for treating melanoma

A substance that comes from pine bark is a potential source for a new treatment of melanoma, according to Penn State College of Medicine researchers.

21 May 2014

Scientists uncover early steps of totipotency in sperm precursors

In the body, a skin cell will always be skin, and a heart cell will always be heart. But in the first hours of life, cells in the nascent embryo become totipotent: they have the incredible flexibility to mature into skin, heart, gut, or any type of cell.

20 May 2014

Cancer Council urges Queenslanders to get to know their own skin

Cancer Council is urging Queenslanders to get to know their own skin and stay vigilant about early detection, with reports of misdiagnosis for some types of melanoma in the Australasian Journal of Dermatology.

19 May 2014

Study to investigate use of OCT in collaboration with Melanoma Institute of Australia

Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography ('OCT') technology, has commenced a clinical study to investigate the use of OCT to diagnose basal cell carcinoma in collaboration with the Melanoma Institute of Australia using Michelson's Diagnostics VivoSight system.

19 May 2014

Bristol-Myers Squibb announces study results of nivolumab drug in patients with renal cell carcinoma

Bristol-Myers Squibb Company today announced results from a Phase 2 and a Phase 1b study of its investigational PD-1 immune checkpoint inhibitor nivolumab in patients with advanced or metastatic renal cell carcinoma (RCC), commonly known as kidney cancer.

16 May 2014

Provectus’ shares to begin trading on NYSE MKT on May 16, 2014

Provectus Biopharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that its shares will begin trading on the NYSE MKT today, Friday, May 16, 2014.

16 May 2014

Bristol-Myers Squibb reports updated survival data from Phase 1b study of advanced melanoma

Bristol-Myers Squibb Company today announced updated survival data from the advanced melanoma cohort of Phase 1b study.

16 May 2014

Phase I study reveals abemaciclib drug shows evidence of single-agent activity in NSCLC patients

Abemaciclib, an oral drug administered twice daily, currently in development by Eli Lilly and Company (NYSE: LLY), has shown evidence of single-agent activity in patients with advanced non-small cell lung cancer in a Phase I study released ahead of the American Society of Clinical Oncology (ASCO) Annual Meeting to be held in Chicago, Ill.

15 May 2014

Sports Authority, MRA partner to educate public about melanoma

Sports Authority, one of the nation's largest full-line sporting goods retailers, today announced that they have partnered with the Melanoma Research Alliance, the largest private funder of melanoma research, to inform the public about this deadly form of skin cancer and to raise funds to support studies aimed at its treatment and cure. This is the fourth consecutive year Sports Authority has participated in and supported the effort.

12 May 2014

Melanoma News and Research

Latest Melanoma News and Research

Biologists show bioelectrical signals control tumors arising from cancer-causing genes, fatty acid

New analysis finds that certain cancers are more concentrated in areas with high poverty

International study provides hope to patients with advanced prostate cancer

Peptide antibodies hit immune-response-stifling MDSCs without harming other vital cells

Research validates family history screening questionnaire as tool to cover multiple conditions

Loyola's pediatric dermatologists highlight risks related to indoor tanning

Mayo Clinic study provides key insights into aggressive form of pancreatic cancer

Research provides key insights into most aggressive form of pancreatic cancer

Substance from pine bark is a potential source for treating melanoma

Scientists uncover early steps of totipotency in sperm precursors

Cancer Council urges Queenslanders to get to know their own skin

Study to investigate use of OCT in collaboration with Melanoma Institute of Australia

Bristol-Myers Squibb announces study results of nivolumab drug in patients with renal cell carcinoma

Provectus’ shares to begin trading on NYSE MKT on May 16, 2014

Bristol-Myers Squibb reports updated survival data from Phase 1b study of advanced melanoma

Phase I study reveals abemaciclib drug shows evidence of single-agent activity in NSCLC patients

Sports Authority, MRA partner to educate public about melanoma

Experimental antibody temporarily halts progression of neuroblastoma in children

Regular doctor visits may reduce melanoma mortality, says study

TGen/George Mason create strategic research alliance to benefit patients with cancer, life-threatening illnesses

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Melanoma News and Research

Latest Melanoma News and Research

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in